Sign-up to Receive
Our Latest Insights

CYBO
VanEck Bionic Engineering UCITS ETF

Fund Description

As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.

  • Invest in companies at the forefront of improving quality of life for the world’s ageing population
  • Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
  • Access companies earning at least half their revenues from bionic engineering-related industries
  • Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco

Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KID and in the sales prospectus. Outperformance not guaranteed.



Underlying Index

MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)

Fund Details
 

  • Fund Ticker

    CYBO

  • Management Company

    VanEck Asset Management B.V.

  • Custodian

    State Street Custodial Services (Ireland) Limited

  • Domicile

    Ireland

  • UCITS Compliant

    Yes

  • Index Ticker

    MVBIONTR

  • Index Provider

    MarketVector Indexes

  • Rebalance Frequency

    Quarterly
1The "Net Asset Value" (NAV) of all ETFs is determined at the close of each business day, and represents the value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell ETF shares at NAV.

2The date the fund was launched prior to quotation on the stock exchange.

 
as of 30 May 2023

  • NAV1

    20.50

  • Shares Outstanding

    260,000

  • Number of Holdings

    25

  • Base Currency

    USD

  • Net Assets

    $5.3M

  • Product Structure

    Physical (Full Replication)

  • Income Treatment

    Reinvestment

  • Distribution Frequency

    None

  • Total Expense Ratio

    0.55%

  • SFDR Classification

    Article 9
  • Fact Sheet
  • VanEck Product List
  • Fund Holiday Calendar

Trading Information as of 30 May 2023

Deutsche
Börse
EUR
Exchange Ticker CIB0
ISIN IE0005TF96I9
SEDOL BMTPPJ3
Bloomberg CIB0 GY
Reuters (RIC) CIB0.DE
Valor --
Bloomberg iNAV CYBOUSIV
Reuters iNAV CYBOEURINAV=IHSM
WKN A3DT2R
Trading Currency EUR
Last Traded Price 19.23
Day's Move -0.10
Volume 1
30 Day Volume 203
VWAP Volume 1

NAVs as of 30 May 2023

Base
Currency 		NAV Daily
Change
NAV 		YTD
Change
NAV 		NAV Price
History 		Total
Expense
Ratio
CYBO USD $20.50 $-0.09 / -0.46% +3.62%
0.55

Performance History* (%)

View All ETFs View All Indices
  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVBIONTR (Index) 5.02 9.15 13.52 4.70 -- -- -- 11.28
  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVBIONTR (Index) 5.13 8.09 8.09 -12.11 -- -- -- 5.96
  2018 2019 2020 2021 2022
MVBIONTR (Index) -- -- -- -- -22.10

Past performance does not predict future returns.

ETF returns are not available if there is less than one year’s performance data.

*Periods greater than one year are annualised.

Investing is subject to risk, including the possible loss of principal. You must read the Prospectus and

KID

before investing, which are available at the Document section of the fund on www.vaneck.com.

ETF performance: Current performance may be lower or higher than average annual returns shown. Discrete performance shows 12-month performance for each of the last 10 years where available. E.g. '1st year' shows the most recent of these 12-month periods and '2nd year' shows the previous 12 month period and so on.

Performance data for the Irish domiciled ETFs is displayed on a Net Asset Value basis, in Base Currency terms, with net income reinvested, net of fees. Brokerage or transaction fees will apply.

Returns may increase or decrease as a result of currency fluctuations.

Index performance: Performance quoted represents past performance of the underlying Index. An index performance is not illustrative of the Product's performance. It is not possible to invest directly in an index: indices are not securities in which investments can be made.

For more information on the Index performance, please consult the Index Provider´s website.

MVIS® Global Bionic Healthcare ESG Index is the exclusive property of MarketVector Indexes GmbH (a wholly owned subsidiary of Van Eck Associates Corporation), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards MarketVector Indexes GmbH (“MarketVector”), Solactive AG has no obligation to point out errors in the Index to third parties. The VanEck Bionic Engineering UCITS ETF is not sponsored, endorsed, sold or promoted by MarketVector and MarketVector makes no representation regarding the advisability of investing in the Fund.

Market Makers

Top 10 Holdings (%) as of 30 Apr 2023 View All Holdings »

Total Holdings: 25
Swipe<br>to view <br> full data
Holding Name
Ticker
 Shares Market Value
(USD) 		% of Net
Assets
MEDTRONIC PLC MDT US 6,726 611,730 10.50
EDWARDS LIFESCIENCES CORP EW US 6,825 600,464 10.30
STRYKER CORP SYK US 1,986 595,105 10.21
DEXCOM INC DXCM US 4,678 567,629 9.74
ZIMMER BIOMET HOLDINGS INC ZBH US 3,188 441,347 7.57
SONOVA HOLDING AG SOON SW 1,126 356,504 6.12
INSULET CORP PODD US 841 267,472 4.59
STRAUMANN HOLDING AG STMN SW 1,614 242,358 4.16
INSPIRE MEDICAL SYSTEMS INC INSP US 741 198,314 3.40
AMPLIFON SPA AMP IM 4,671 171,618 2.94
Top 10 Total (%) 69.53
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 30 Apr 2023

  • Country

    % of Net Assets
  • ■

    United States

    77.51
  • ■

    Switzerland

    10.27
  • ■

    Italy

    2.94
  • ■

    Australia

    2.71
  • ■

    United Kingdom

    2.64
  • ■

    China

    2.05
  • ■

    Denmark

    1.68
  • ■

    Other/Cash

    0.18

Sector Weightings (%) as of 30 Apr 2023

  • Sector

    % of Net Assets
  • ■

    Health Care

    99.8
  • ■

    Other/Cash

    0.2

Technology

Sustainable

Crypto

Metal

Real Estate

Dividend

Discover more ETFs

More ETFs